» Articles » PMID: 33610690

Cardiovascular Risk Factors and Prevention: A Perspective From Developing Countries

Overview
Journal Can J Cardiol
Publisher Elsevier
Date 2021 Feb 21
PMID 33610690
Citations 113
Authors
Affiliations
Soon will be listed here.
Abstract

By the beginning of the 21st century, cardiovascular disease (CVD) had become the leading cause of premature mortality and morbidity worldwide, with 80% originating from less developed lower-income countries in line with societal and economic developments. Extensive research on causes and risk factors have been carried out since the mid-20th century and have established individual factors such as smoking, hypertension, diabetes, and dyslipidemia as CVD risk factors, followed by others. Two recent major case-control studies have summarized the role of common major CVD risk factors in determining the risk of myocardial infarction (INTERHEART study) and stroke (INTERSTROKE study). They showed that 9 and 10 common risk factors accounted for > 90% of the risk of myocardial infarction and stroke, respectively, and established the focus in prevention of these common CVDs. The efficacy of lowering blood pressure, blood glucose, and lipid-lowering therapies has been shown to reduce subsequent morbidity and mortality. Leading international health organizations have published guidelines that are updated regularly to set the standards for providing guidance for implementation and management of risk factors. Interventions can also be costly and long-term adherence, essential to be effective in reducing risks, tends to decrease drastically with time. Dietary recommendations have been incorporated into national and professional guidelines for CVD prevention since the 1960s. On the basis of new research, some existing dietary recommendation might be outdated and should be reviewed, and revised, if necessary. A perspective of CVD prevention and treatment in developing countries is highlighted.

Citing Articles

Cholesterol, high-density lipoprotein, and glucose index versus triglyceride-glucose index in predicting cardiovascular disease risk: a cohort study.

Mo D, Zhang P, Zhang M, Dai H, Guan J Cardiovasc Diabetol. 2025; 24(1):116.

PMID: 40065297 PMC: 11895360. DOI: 10.1186/s12933-025-02675-y.


Ignored or underestimated - evaluation and treatment of cardiovascular risk factors in patients with adrenal insufficiency.

Wasmuth A, van de Loo I, Domberg J, Harbeck B Endocrine. 2025; .

PMID: 40000548 DOI: 10.1007/s12020-025-04192-0.


[Causal Relationship Between Components of Metabolic Syndrome and Endometrial Carcinoma].

Yang M, Hu Y, Guo W, Yang F, Qi X, Zheng Y Sichuan Da Xue Xue Bao Yi Xue Ban. 2025; 55(6):1557-1566.

PMID: 39990839 PMC: 11839343. DOI: 10.12182/20241160109.


Considerations on the sustainability of hypercholesterolemia treatment in the context of new drugs on the market: data from Campania, Italy.

Ferrara F, Zovi A, Langella R, Panico A, Scognamiglio M, Trama U Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39921732 DOI: 10.1007/s00210-025-03862-0.


The effect of magnesium supplementation on serum concentration of lipid profile: an updated systematic review and dose-response meta-analysis on randomized controlled trials.

Hariri M, Sohrabi M, Gholami A Nutr J. 2025; 24(1):24.

PMID: 39905454 PMC: 11796098. DOI: 10.1186/s12937-025-01085-w.